menu
Global Interventional Neurology Market Size, Rvenue & Share
Global Interventional Neurology Market Size, Rvenue & Share
Interventional neurology is an endovascular, catheter-based technique used to diagnose and treat central nervous system vascular disease. Other factors such as technological advancements, the presence of a large target patient population,

Interventional neurology is an endovascular, catheter-based technique used to diagnose and treat central nervous system vascular disease. Other factors such as technological advancements, the presence of a large target patient population, favourable medical reimbursements, and rising demand for effective neurovascular devices are also expected to drive market growth. Interventional neurology devices use non-invasive and image guided treatments to treat neurovascular illnesses such as arteriovenous malformations, aneurysms, stroke, and cavernous malformations. Furthermore, rapid geriatric population growth, ongoing product development and commercialization, expansion of healthcare infrastructure across emerging markets, and favourable medical reimbursements are major drivers that will propel the interventional neurology devices market forward.

 

Product type, indication, end-user, and region can all be used to segment the Global Interventional Neurology Market. The market can be divided into coiling and embolization devices, angioplasty and stenting systems, support devices, and neurothrombectomy devices based on product type. Embolic coils, liquid embolic agents, and flow diverting devices are sub-segments of the coiling and embolization devices segment. Carotid artery stents and embolic protection systems are two types of angioplasty and stenting systems. Microcatheters and guidewires are examples of support devices. The market can be divided into cerebral aneurysms, ischemic stroke, arteriovenous malformations, and others based on indication. The market can be divided into hospitals, ambulatory surgical centres, clinics, and other end-users.

 

 

Read More@ https://bit.ly/3Du03uz